Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2021 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Access to novel drugs and therapeutics for children and youth: Eliciting citizens' values to inform public funding decisions.
Health Expect. 2023 Apr;26(2):715-727. doi: 10.1111/hex.13697. Epub 2023 Jan 14.
Health Expect. 2023.
PMID: 36639959
Free PMC article.
The CADTH pCODR Expert Review Committee Process Explained. Comment on Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain. Curr. Oncol. 2022, 29, 9891-9895.
Trudeau M, Fraser B.
Trudeau M, et al. Among authors: fraser b.
Curr Oncol. 2023 May 16;30(5):5047-5049. doi: 10.3390/curroncol30050380.
Curr Oncol. 2023.
PMID: 37232838
Free PMC article.
Item in Clipboard
Building a National Reassessment Process for Oncology Drugs: Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration through a Simulated Reassessment Exercise.
Dai WF, Craig E, Fraser B, Chambers A, Mai H, Brown MB, Earle CC, Evans WK, Geirnaert M, Taylor M, Trudeau M, Sperber D, Beca JM, Denburg A, Mercer RE, Parmar A, Tadrous M, Takhar P, Chan KKW, On Behalf Of The CanREValue Collaboration.
Dai WF, et al. Among authors: fraser b.
Curr Oncol. 2021 Nov 12;28(6):4645-4654. doi: 10.3390/curroncol28060392.
Curr Oncol. 2021.
PMID: 34898572
Free PMC article.
Item in Clipboard
Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's Reassessment and Uptake Working Group.
Dai WF, Arciero V, Craig E, Fraser B, Arias J, Boehm D, Bosnic N, Caetano P, Chambers C, Jones B, Lungu E, Mitera G, Potashnik T, Reiman A, Ritcher T, Beca JM, Denburg A, Mercer RE, Parmar A, Tadrous M, Takhar P, Chan KKW, On Behalf Of The CanREValue Collaboration Reassessment And Uptake Working Group.
Dai WF, et al. Among authors: fraser b.
Curr Oncol. 2021 Oct 16;28(5):4174-4183. doi: 10.3390/curroncol28050354.
Curr Oncol. 2021.
PMID: 34677272
Free PMC article.
Item in Clipboard
Drug costs in Canada.
Fraser B.
Fraser B.
Can Pharm J (Ott). 2017 Jul 7;150(4):227. doi: 10.1177/1715163517711144. eCollection 2017 Jul-Aug.
Can Pharm J (Ott). 2017.
PMID: 29163718
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite